Biohaven Ltd. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Biohaven Ltd. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($173.44M) | Nov 10, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($198.15M) | Aug 11, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($221.68M) | May 12, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($160.30M) | Nov 10, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($319.77M) | Aug 11, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($179.50M) | May 12, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($102.57M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($90.35M) | Aug 9, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($70.49M) | May 9, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($68.85M) | Nov 14, 2023 |
| Q3 | 2022 | Jun 30, 2022 | ($203.29M) | Nov 9, 2022 |
| Q2 | 2023 | Jun 30, 2022 | ($203.29M) | Jul 31, 2023 |
| Q3 | 2022 | Mar 31, 2022 | ($97.03M) | Nov 9, 2022 |
| Q1 | 2023 | Mar 31, 2022 | ($97.03M) | May 12, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($54.37M) | Nov 9, 2022 |
| Q3 | 2022 | Jun 30, 2021 | ($45.42M) | Nov 9, 2022 |
| Q3 | 2022 | Mar 31, 2021 | ($62.12M) | Nov 9, 2022 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($169.38M) | Nov 10, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($211.70M) | Aug 11, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($221.56M) | May 12, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($178.17M) | Nov 10, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($333.77M) | Aug 11, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($183.24M) | May 12, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($110.55M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($94.01M) | Aug 9, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($77.78M) | May 9, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($67.64M) | Nov 14, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($197.11M) | Jul 31, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($89.77M) | May 12, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($55.49M) | Nov 9, 2022 |